Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-825-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Some information in this page has been claimed confidential.
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- OECD 422
- Type of information:
- other: read-across from supporting substances (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2005
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- only Japanese translation available
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Test material form:
- solid
- Details on test material:
- at room temperature appears as a yellow waxy paste
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: lot number 308251 from Taiyo Kagaku (Mie)
- Purity: 99.93%
STABILITY AND STORAGE CONDITIONS:
- Storage condition of test material:
stored under cool and dark condition (2 to 6°C)
- Storage condition of vehicle: corn oil stored in a cold place (2-6 °C), tightly closed under lighy shielding until use
It was confirmid that the test substance under storage conditions and dosage form was stable
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan (Kanagawa)
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Age at study initiation: 10 weeks
- Weight at study initiation: The mean body weight for male 372 (352 to 426) g and for female 224 (192 to 249) g
- Housing: wire mesh cage and raised with solid feed (Lab MR Stock, Nippon Nogyo Sangyo). Females after mating confirmation were placed in a polycarbonate cage containing nest-making material (White Flake, Japan Charles River).
- Diet: ad libitum
- Water: ad libitum
- Recovery period: 14 days
DETAILS OF FOOD AND WATER QUALITY:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.1°C - 23.2°C
- Humidity (%): 48-61%
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Remarks:
- Nacalai Tesque
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Dosage of the test sustance is prepare as a solution with a concentration to give prescribed dose by using solvent oil (Nacalai Tesque) as a solvent
DIET PREPARATION
- Type of food: solid food
VEHICLE
- Justification for use and choice of vehicle (if other than water): 9-cis-octadecenoic acid (2,3-dihydroxypropyl) ester is insoluble in water but is soluble in food oil - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Method of administration:using a syringe fitted with Teflon stomach sonde, once a day (in the morning), Males were administered for 42 days, starting two weeks before mating. Females were administered staring two weeks before mating, during mating, pregnancy and until 4 days post-partum. Males and the female satellite group were orally administered for 42 days. Corn oil was similarly administered to the control group.
- Frequency of treatment:
- daily in the morning
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 5 animals for each dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: As a dose setting test, the test substance was repeatedly administered orally at doses of 0, 100, 300, and 1000 mg / kg for 14 days to 5 rats of each group. Weight and food consumption measurements, hematology and blood biochemical examination, necropsy and measurement of organ weights were carried out. As results, toxic effects due to administration were not observed. Therefore, the dose in this study was 1000 mg / kg / day as the highest dose, then 3 doses of 300 and 100 mg / kg / day.
- Post-exposure recovery period: was set in 14 days.
Examinations
- Parental animals: Observations and examinations:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: On the day before the start of administration and then once a week
- Parameters checked: ease of withdrawal from the cage, ease of handling when exiting the cage, body tension (relaxation - tonic), skin (color), coat, piloerection, ocular secretion, eyelid closure state, eyes projection, lacrimation, mouth nose stains (dirt), salivation, urine contamination of the lower abdomen coat, stains around the anus, vocalization, respiration, posture, convulsions, tremor, search behavior (arousal level), alertness, locomotor activity abnormal behaviors (self bite, retrograde walking, etc.), stereotyped (excessive hair repair, repeated swiveling motion, etc.), consciousness failure (confusion, catalepsy, coma), limb muscle tone degree, urination, and excretion.
BODY WEIGHT: Yes
- Time schedule for examinations: once a week and on the date of slaughter
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
The consumption of food was measured once a day for 24 hours on a daily basis.
HAEMATOLOGY: Yes
- Time schedule for collection of blood: 5pm (during administration period and the day after the completion of the recovery perid)
- Anaesthetic used for blood collection: Not specified
- Animals fasted: Not specified
- Parameters checked: red blood cells count, hemoglobin amount, hematocrit, MCV, MCH,MCHC, white blood cells count, platelet count prothrombin time, total protein, albumin, A/G ratio, glucose, triglyceride, total cholesterol, total bilirubin, urea nitrogen, creatinine, AST,
ALT, g-GTP, ALP, LDH, cholinesterase, calcium and inorganic phosphorus, sodium, potassium and chlorine
URINALYSIS: Yes /
- Metabolism cages used for collection of urine: Yes
Animals were housed in a metabolism cage for 40 days (males) and on 8 days on recovery for satellites.
- Parameters checked: observation of appearance, Qualitative inspection of pH, occult blood, protein, sugar, ketone bodies, bilirubin, urobilinogen and examination of sediment. Further, for urine obtained by storing for 18 hours, urine volume, specific gravity and sodium and potassium.
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examamination: Males were administered 41 days after females, once during feeding period, and on the final administration day and recovery day 13 for males and females of the satellite group
- Battery of functions tested: sensory activity / grip strength / motor activity / other: the landing foot width, grip strength of forelimb and hindlimb, spontaneous momentum ( males for 30 minutes and 60 minutes, females for 30 minutes). Spontaneous momentum of female of satellite group was also measured for 60 minutes. Males in the final administration day, females once during the feeding period, males and females of the satellite group were examined about receive auditory reaction, visual reaction, tactile reaction, ear response Injection, pain sensation response, pupillary reflex, ipsilateral flexor reflex, eyelid reflex and right flank reflex. - Oestrous cyclicity (parental animals):
- For females, vaginal plaque smears by Giemsa staining were prepared and examined by microscopic examination to study the sexual cycle stages until mating. It was confirmed following the acclimatization / quarantine period.
The mean periodicity was defined as the average number of days after the estrus late period where only keratinocytes are scattered or agglomerated. - Sperm parameters (parental animals):
- not specified
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
PARAMETERS EXAMINED
The following parameters were examined in [F1] offspring:
[number and sex of pups, stillbirths, live births, postnatal mortality, presence of anomalies, weight gain]
- Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals
- Maternal animals: All surviving animals
GROSS NECROPSY
- Gross necropsy consisted of [external and internal examinations including the cervical, thoracic, and abdominal viscera.]
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Table [4 of the attached background material] were prepared for microscopic examination and weighed, respectively.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No change due to administration of the test substance was observed during the administration period and during the recovery period.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- A small tumor was confirmed in the lower abdomen after 40 days of administration in one female of the 300 mg / kg group.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- There was no significant change in body weight and weight gain during the administration period. (for results see Fig.1, 2.1 and 2.2 in the attachment)
During the recovery period, body weight gain of a male in the 1000 mg / kg group showed a significant high value, but this was due to the low value trend of weight gain of the control group rather - Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- No change due to administration of the test substance was observed during the administration period and during the recovery period.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- No change due to administration of the test substance was observed. (for results see table 2 in the attachment)
There was a somewhat lower value overall compared to the control group, and a significant difference was observed in the 100 mg / kg group and the 300 mg / kg group, but no dose correlation was observed in the change.
In the examination at the end of the recovery period, no significant change was observed in each examination item. - Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- At the end of the administration period, significant levels of inorganic phosphorus were observed in females at 300 mg / kg group and 1000 mg / kg group. These values correspond to the control group. Although dose correlation was not clear. (for results see table 3 in the attachement).
In the examination at the end of the recovery period female cholinesterase in the 1000 mg / kg group showed a significant high value. - Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- No change due to administration of the test substance was observed during the administration period and during the recovery period. (for results see table 1 in the attachment)
- Behaviour (functional findings):
- no effects observed
- Description (incidence and severity):
- No significant change was observed in each examination item in the examination at 6 weeks of administration and 2 weeks of recovery.
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, non-treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No change due to administration of the test substance was observed. (for results see tables 5 and 6 in the attachment)
- Histopathological findings: neoplastic:
- no effects observed
- Description (incidence and severity):
- No change due to administration of the test substance was observed. (for results see tables 5 and 6 in the attachment)
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- In the sexual cycle examination from the day after grouping to before mating, each individual regained estrus at 3.7 to 5.0 days, and the average periodicity of each administration group including the control group shows 4.0 to 4.1 days. No significant change was observed.
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- copulation rate: a pair of mating failed was found in the 1000mg/kg group. and one pair that did not became pregnant were established in the control group. Mating was established in all the other cases. There was no significant change in the number of days required for establishment, mating and conception rate.
Females that failed to copulate had a good sex cycles.
Number of corpus luteum, number of implantation and implantation rate not show significant changes.
Details on results (P0)
No abnormality was found in the condition of feeding and nursing.
Effect levels (P0)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- haematology
- clinical biochemistry
- urinalysis
- organ weights and organ / body weight ratios
- histopathology: non-neoplastic
- histopathology: neoplastic
- reproductive function (oestrous cycle)
- reproductive performance
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Results: P1 (second parental generation)
Effect levels (P1)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- haematology
- urinalysis
- organ weights and organ / body weight ratios
- histopathology: non-neoplastic
- histopathology: neoplastic
- reproductive function (oestrous cycle)
- reproductive performance
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- there were no significant changes in the total number of births per litter, delivery rate, neonatal number and body weight at nursing 0 and 4, birth rate, sex ratio and survival rate on 4th day of nursing. There was no changes in the general condition of the newborns.
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- there was no significant change in the total number of births per litter, delivery rate, sex ratio and survival rate on 4th day of nursing. There was no changes in the general condition of the newborns.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- there was no significant change in the body weight at nursing 0 and 4 and survival rate on 4th day of nursing. There was no changes in the general condition of the newborns.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- no significant changes were observed.
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Histopathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- a small number of visceral mutations were observed, but all are within the normal range (0 to 6.4%) ofa background data.
- Other effects:
- not examined
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not examined
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not examined
Details on results (F1)
Effect levels (F1)
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- clinical signs
- mortality
- body weight and weight gain
- food consumption and compound intake
- histopathology: non-neoplastic
- histopathology: neoplastic
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
Any other information on results incl. tables
Changes in the sexual cycle (female), mating period, mating rate, conception rate, pregnancy period, luteinum number, implantation rate, birth rate and delivery rate were not observed in relation to the reproductive ability of the parent animal
No abnormality was found in the condition of feeding and nursing.
Applicant's summary and conclusion
- Conclusions:
- NOAEL= 1000 mg/kg/day.
- Executive summary:
From the above results, it was concluded that non-toxic level of reproductive capacity in male and female parents is 1000 mg/kg/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies